Alternative / Rapid Microbiological Methods RMM
|
|
- Samson Tracy Norman
- 5 years ago
- Views:
Transcription
1 Alternative / Rapid Microbiological Methods RMM IMB GMP Information Seminar, Crowne Plaza 27 th September 2012 Greg McGurk, Executive Inspector Slide 1
2 Scope Introduction The Myths Considerations Validation Current Situation Slide 2
3 Introduction RMM is a unifying term that covers a wide range of detection technologies. The different technologies can be grouped in three types: Growth based Direct measurement Cell components analysis Each of these technologies have their own advantages and limitations and all need of specialist microbiological knowledge for their implementation Slide 3
4 Introduction Growth Based Methods Early Detection of Growth: Electrochemical Methods Measurement of gas Bioluminescence Microcalorimetery Turbidimetry Slide 4
5 Introduction Direct Measurement Solid Phase Cytometry Flow Cytometry Direct Epifluorescence Filtration Technique (DEFT) Slide 5
6 Introduction Cell Component Analysis Phenotypic & Genotypic Identification Phenotypic & genotypic systems are widely used within laboratories Biochemical reaction (API kits) DNA replication techniques PCR (Polymerase Chain Reaction); Single cell detection through presence of DNA, results in around one hour(+). Slide 6
7 Introduction Why Conventional methods typically slow, between 5 14 days incubation Corrective actions Reactive to historical data RMM Enable a proactive approach RMM Enable quicker response to out of specification / out of trend results Real time / near real time results Earlier corrective actions Slide 7
8 The Myths Regulators do not support introduction of Alternative / Rapid micro methods IMB and other agencies actively encourage introduction of such methods Openly discuss various methods with vendors / manufacturers IMB encourages meetings with manufacturers looking to introduce an alternative / rapid micro method Slide 8
9 The Myths Rapid Micro methods will never fully replace finished product testing Already happening Slide 9
10 The Myths Rapid Micro methods will result in changes to specifications /acceptance levels Some RMMs, especially those that do not rely on growth, may provide a higher recovery count as compared with traditional methods. Can correlate the new measurements, such as a fluorescing unit, with the old measurement (i.e., colony forming units) and establish new acceptance levels. Slide 10
11 The Myths Rapid Micro methods will solve all contamination issues Not necessarily true. BUT : Rapid methods can support a comprehensive contamination control program, and when contamination arises, RMMs can be used as investigative tools. Better than waiting days or weeks for micro results. Slide 11
12 Considerations 3 major types of microbiological methods 1. Qualitative 2. Quantitative 3. Identification Consider what it is you want to achieve and what you need to utilise the method for Slide 12
13 Considerations Applicability Information should be scientifically justified and limitations not as severe as conventional Method The RMM technology to be used in each case will be limited by the type of test. Not all technologies can be used for all determinations. The validation requirements will also be different depending on the type of test. Slide 13
14 Considerations Use of RMM Different types of microbiological tests are performed during manufacture of a pharmaceutical product: Raw material bioburden Pre-filtration bioburden Microbial purity Sterility Utility monitoring (ie: process water, compressed gas) Environmental monitoring (ie: air, surfaces, personnel) Others Any of these tests could be replaced by a RMM. Slide 14
15 Considerations Risk Benefit analysis - Defined purpose for the test method - Define the type and depth of information required - Limitations of the conventional method Comparative risk-benefit analysis Conventional Vs Alternative method Slide 15
16 Considerations Validation Ph.Eur Alternative methods for control of microbial quality Satisfactory completion of DQ, IQ and OQ including compliance with Annex 11 should be confirmed Comparative study against Pharmacopoeial method Any alternative method must be proven to be, at least, equivalent to the method described in the Pharmacopoeia Slide 16
17 Considerations Validation The validation of the RMM should include: The evaluation of metabolically and physically injured cells, starved cells and spores, where applicable Cells grown under ideal and adverse conditions to determine any differences Environmental isolates The results should be compared against the compendial method Slide 17
18 Considerations Non Destructive id of isolates Site flora diversity Vs those qualified Detection of new or stressed flora Potential Interference Product Background Slide 18
19 Considerations False Negative or Positive results Assess new test process for potential issues. E.g. Impact of machine hotspots on media fertility? Machine/instrument breakdown and impact to test samples? Microbiologist variation Slide 19
20 Considerations Result Handling Beware of data overload Understand what you want from the data. Understand what the method data is telling you. Higher Counts Observed A problem with the process? Increased sensitivity of methods? Assess the data Slide 20
21 Current Situation Qualitative Quantitative Identification Growth Based Methods Direct Methods Cell Component Methods Not so Widespread Widespread Slide 21
22 Current Situation Large number of companies utilising rapid ID techniques Quantitative techniques routinely used in Biological processes IPC E.g. cell viability tests Slow uptake on other test types Mainly growth based methods water testing Slide 22
23 Current Situation Very limited number of RMM applications Several vendors have presented their technologies to the IMB. Encourage manufacturers considering use of RMM to approach IMB for meeting with Inspectors and Assessors Slide 23
24 In Summary European Pharmacopeia Chapter provides detailed guidance. IMB welcomes their adoption and encourages company s to engage with IMB on them The IMB do not endorse or certify any vendor or their technology whether or not the vendor has approached the IMB. The responsibility for the applicability and adequacy of the method remains with the testing laboratory/manufacturing site. Slide 24
25 Thank You for Listening Slide 25
Rapid Microbiological. PDA: A Global. Methods. Association. Gilberto Dalmaso Aseptic Processes Development Manager
Rapid Microbiological PDA: A Global Methods Association Gilberto Dalmaso Aseptic Processes Development Manager ARMM Presentation Outline A Rapid History of Microbiology The Fundamentals of Traditional
More informationRapid Microbiological Methods Understanding the Technologies and Regulatory Expectations for Validation and Implementation
Rapid Microbiological Methods Understanding the Technologies and Regulatory Expectations for Validation and Implementation Michael J. Miller, Ph.D. President Microbiology: Where We ve Been 1683. Anton
More informationRapid Methods & Technologies
2013 Laboratory Conference: Unraveling the Mystery of Pharmaceutical Laboratory Science Rapid Methods & Technologies Finding the Guilty Party Faster! James Spedding MT (ASCP) EMD Millipore Lab Solutions
More informationBest Practices and Application of GMPs for Small Molecule Drugs in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C.
Best Practices and Application of GMPs for Small Molecule Drugs in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C. Manufacturing Breakout Session 1 Survey Results: Drug Product Manufacturing
More informationRapid Microbial Methods (RMM) Christopher A Bravery
Rapid Microbial Methods (RMM) Christopher A Bravery cbravery@advbiols.com 1 Pharmacopoeial Methods 14d (full results) Validated (subject to matrix/interferance) USP 71; EP 2.6.1 etc. 2 1 EP 2.6.27 Microbial
More informationIntroduction to RAPID MICROBIAL METHODS. Presented By: Erin Patton, Sr. Product Specialist
Introduction to RAPID MICROBIAL METHODS Presented By: Erin Patton, Sr. Product Specialist DISCUSSION AGENDA 1 Impact of Rapid Methods 2 Cost Savings from Rapid Methods 3 Considerations When Choosing a
More informationEuropean Pharmacopoeia Chapter Alternative methods for control of microbiological quality
EDQM Symposium on Microbiology 10-11 October 2017 11/10/2017 European Pharmacopoeia Chapter 5.1.6 Alternative methods for control of microbiological quality Sébastien Jouette, Ph. D. Scientific programme
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. This document is for consultation until 11 December 2015
Ref. Ares(2015)3808922-15/09/2015 EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Medicinal Products Quality, Safety and Efficacy Brussels, [date] This document is for consultation until 11
More informationEuropean Pharmacopoeia
EXAMPLES OF VALIDATION PROTOCOLS OF THE ALTERNATIVE MICROBIOLOGICAL METHODS ACCORDING TO CHAPTER 5.1.6 Alternative methods for control of microbiological quality European Pharmacopoeia EDQM Edition 2018
More informationMilliflex Quantum Detection of microbial contaminants in water samples
Application Note Quantum Detection of microbial contaminants in water samples Water is a key raw material utilized in the manufacturing of products within the pharmaceutical, biopharmaceutical and healthcare
More informationALTERNATIVE METHODS FOR CONTROL OF MICROBIOLOGICAL QUALITY
5.1.6. Alternative methods for control of microbiological quality EUROPEAN PHARMACOPOEIA 6.0 01/2008:50106 5.1.6. ALTERNATIVE METHODS FOR CONTROL OF MICROBIOLOGICAL QUALITY The following chapter is published
More informationMICROBIOLOGY AND NEW TECHNOLOGY HOW TECHNOLOGY CAN IMPACT ON MICROBIOLOGICAL CONTROL
MICROBIOLOGY AND NEW TECHNOLOGY HOW TECHNOLOGY CAN IMPACT ON MICROBIOLOGICAL CONTROL DISCUSSION AREAS HOW MICROBIOLOGY NEEDS TO CHANGE TO MEET FUTURE DEMANDS AND PRODUCTION SYSTEMS MICROBIOLOGY AND PAT
More informationAt Your ServIce. Microbiology Services. The life science business of Merck operates as MilliporeSigma in the U.S. and Canada.
At Your ServIce Microbiology Services The life science business of Merck operates as MilliporeSigma in the U.S. and Canada. Microbiology Services Optimize your QC lab workflow and ensure regulatory compliance
More informationGUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PH 1/97 (Rev. 3), 15 January 2002 ANNEX 15 QUALIFICATION AND
More informationStreamline your microbial detection workflow with the Milliflex platform.
Streamline your microbial detection workflow with the Milliflex platform. Milliflex platform overview Looking for reliable bioburden testing that won't keep you waiting for the accurate results you need?
More informationLABORATORY COMPLIANCE
1 LABORATORY COMPLIANCE Jeanne Moldenhauer Vectech Pharmaceutical Consultants, Inc. Farmington Hills, MI INTRODUCTION Implementation of the Systems-Based Inspection Guideline for drug manufacturers in
More informationErin Patton, MS Senior Product Specialist Charles River Labs, Microbial Solutions
Validation of a Rapid Microbial Method Approach to Validation Case Studies: Equivalence Verification of an Alternate Assay for Microbial Limits Screening and Sterility Testing of Pharmaceutical Products
More informationUSP <1223> Revision and the Alternative Microbiological Methods Workshop Tony Cundell, Ph. D. Consulting Microbiologist, Scarsdale, New York, USA
USP Revision and the Alternative Microbiological Methods Workshop Tony Cundell, Ph. D. Consulting Microbiologist, Scarsdale, New York, USA September, 2015 biomerieux Meeting 1 Presentation Outline
More informationAseptic Process Validation
Aseptic Process Validation IMB GMP Information Seminar 27 th September 2012 Gerard Sheridan, Inspector Date Insert on Master Slide Slide 1 Overview Guidance Best Practices Common Deficiencies Slide 2 Aseptic
More informationStreamline your microbial detection workflow with the Milliflex platform.
Streamline your microbial detection workflow with the Milliflex platform. EMD Millipore is a division of Merck KGaA, Darmstadt, Germany Milliflex platform overview Looking for reliable bioburden testing
More informationMethod validation is the process used to confirm that
Developing a Validation Strategy for Rapid Microbiological Methods Michael J. Miller, Ph.D. President, Microbiology Consultants, LLC All analytical methods need to be validated prior to their introduction
More informationPreparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014
Preparing Your Aseptic Processing Facility for an FDA Inspection Valerie Welter, Director Quality Bayer HealthCare March 10, 2014 Agenda Regulatory Requirements Establishing your Approach Aseptic Controls
More informationComplaints Investigations Root Cause Analysis
Complaints Investigations Root Cause Analysis Dr. Ademola Daramola International Relations Specialist Drugs US FDA India Office New Delhi February 22nd 2018 Information presented in this presentation does
More informationMicrobiological Cleaning Method Validation
Microbiological Cleaning Method Validation The purpose of cleaning procedures should never be to reduce bioburden to an acceptable level! Fergus O Connell QA Manager Eurofins ams Laboratories www.eurofins.com
More informationSupplementary Training Modules on Good Manufacturing Practice. Validation. WHO Technical Report Series, No. 937, Annex 4.
Supplementary Training Modules on Good Manufacturing Practice Validation WHO Technical Report Series, No. 937, 2006. Annex 4. Validation Slide 1 of 48 August 2006 Validation! Part 1. General overview on
More information[PPT PDF] Pharmaceutical Water System Design Validation - Microbial Testing of Water is discussed in detail in this article.
[PPT PDF] Pharmaceutical Water System Design Validation - Microbial Testing of Water is discussed in detail in this article. Pharmaceutical Water System: Classical Culture Approach for microbial testing
More informationRaad voor Accreditatie (Dutch Accreditation Council RvA) Explanatory document on microbiology
Raad voor Accreditatie (Dutch Accreditation Council RvA) Explanatory document on microbiology Document code: A RvA-Explanatory note describes the policy and/or the procedures of the RvA concerning a specific
More informationReview Validation of aseptic processes for pharmaceuticals
OPEM www.opem.org Oriental Pharmacy and Experimental Medicine 2010 10(4), 231-238 DOI 10.3742/OPEM.2010.10.4.231 Review Validation of aseptic processes for pharmaceuticals Lincy Joseph*, Mathew George
More informationDate: 17/12/2012 Reviewed: 21/12/2012 Issue: 2 SI No: P3149 Prepared by: G.Ostacchini Reviewed by: A.Green Approved by: D. Johnson
Page 1 of 8 Date: 17/12/2012 Reviewed: 21/12/2012 Issue: 2 SI No: P3149 Prepared by: G.Ostacchini Reviewed by: A.Green Approved by: D. Johnson Title: GAMMA STERILIZATION AND REVALIDATION GUIDANCE & PROCEDURE
More informationPharmaceutical Reference Standards: Overview and Role in Global Harmonization
Matthew Borer, Ph.D., Advisor Pharmaceutical Reference Standards: Overview and Role in Global Harmonization 3rd DIA China Annual Meeting Beijing, China, 16-18 May, 2011 What is a Pharmaceutical Reference
More informationWorking document QAS/11.415/Rev. 1 August 2011 RESTRICTED DRAFT FOR COMMENT
/Rev. 1 August 2011 RESTRICTED DRAFT PROPOSAL FOR Revision of General method in the 4th Edition of The International Pharmacopoeia 3.3 MICROBIAL Quality PURITY OF PHARMACEUTICAL PREPARATIONS (August 2011)
More informationIndustry Perspective on Manufacturing in Early Development
Industry Perspective on Manufacturing in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C. Eric Schmitt AbbVie IQ Drug Product Manufacturing Working Group August 2012 issue of Pharmaceutical
More informationEUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS
EUROPEAN INDUSTRIAL PHARMACISTS GROUP Guidance on CPD for QUALIFIED PERSONS EIPG Guidance on CPD for QP Continuing Professional Development for Qualified Persons, Technical Directors and other Responsible
More informationManaging Your Environmental Isolates
Managing Your Environmental Isolates The Controversy Good practice includes the periodic challenge of prepared media with low levels of organisms. This includes USP indicator organisms as well as normal
More informationReal Time Microbial Detection
Melbourne July 2017/R. Strebel Real Time Microbial Detection Global Pharmacopeia Acceptance of Alternative Methods Agenda 2 1 Introduction 2 Pharmaceutical Water Monitoring and Analysis 3 Why On-line Microbial
More informationProviding clear solutions to microbiological challenges TM. cgmp/iso CLIA. Polyphasic Microbial Identification & DNA Fingerprinting
Providing clear solutions to microbiological challenges TM Cert. No. 2254.01 Polyphasic Microbial Identification & DNA Fingerprinting Microbial Contamination Tracking & Trending cgmp/iso-17025-2005 CLIA
More informationExcipients Facing Increased Scrutiny How to Use Secondary Reference Standards to Help Maintain Regulatory Compliance
Excipients Facing Increased Scrutiny How to Use Secondary Reference Standards to Help Maintain Regulatory Compliance by Tom Savage, NSF International Since 2008, when patient deaths were first linked to
More informationPrequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer
Prequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT API Manufacturer WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer Part 1: General information Name of Manufacture Unit number
More informationMicrobiology Testing: USP requirements for Sterile and Nonsterile Preparations Webinar Q&A
USP Antimicrobial Effectiveness Testing Microbiology Testing: Webinar Q&A 1. If a base ingredient is designed for the purpose of compounding a specific type of preparation does this forgo the necessity
More informationQuality Assessment & GMP Similarities & Differences
Quality Assessment & GMP Similarities & Differences EMEA, Monday 26 th October 2009 Cormac Dalton Inspector Irish Medicines Board Date 12-Oct-09 Slide 1 Content Overview of commonalities & differences
More informationThe Application of Pharmaceutical cgmp to Live Bacterial Products. James Harris Business Development Manager
The Application of Pharmaceutical cgmp to Live Bacterial Products James Harris Business Development Manager The Objective CMC expectations of a cgmp live bacterial biopharmaceutical project Overview Define
More informationInspection. Implementation of ICH Q8, Q9, Q10
Implementation of ICH Q8, Q9, Q10 International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Outline Aim of - as a key part of the regulatory
More informationGOOD MANUFACTURING PRACTICE
GOOD MANUFACTURING PRACTICE Introduction The first WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth World Health Assembly
More informationSwab and Samplers Test Kits Quality control as easy as 1, 2, 3
Swab and Samplers Test Kits Quality control as easy as 1, 2, 3 Merck Millipore is a division of Environmental monitoring Sample, incubate, count Merck Millipore s Samplers and Swab Test Kits simplify routine
More informationQuality Risk Management. of the GDP Supply Chain. Dr Cormac Dalton Inspector. Crowne Plaza Hotel, 25/2/2010. Date 22-Feb-10 Slide 1
Quality Risk Management of the GDP Supply Chain Crowne Plaza Hotel, 25/2/2010 Dr Cormac Dalton Inspector Date 22-Feb-10 Slide 1 Supply Chain Experiment Pharmaceutical excipient ordered 3 rd December 09
More informationISO INTERNATIONAL STANDARD
INTERNATIONAL STANDARD ISO 14160 First edition 1998-03-15 Sterilization of single-use medical devices incorporating materials of animal origin Validation and routine control of sterilization by liquid
More informationA24 CALA Checklist for Microbiology Revision 4.1 February 16, 2018
A24 CALA Checklist for Microbiology Revision 4.1 February 16, 2018 Laboratory Name: Appendix Name: Appendix Number: Assessor: Date: Rev. 4.1 CALA CHECKLIST FOR MICROBIOLOGY Item 01 SAMPLING AND SAMPLE
More informationMaterials Management Traceability, CEPs and managing non-conforming sites
Materials Management Traceability, CEPs and managing non-conforming sites IMB Information Day, 14 th October 2010 Dr Cormac Dalton Inspector 13-Oct-10 Slide 1 Managing Supply Supply Demand Supply chain
More informationRobert Westney, M.S., RAC, CMQ/OE Director of Quality and Operations Cryologics, Inc. March 7, 2017
Robert Westney, M.S., RAC, CMQ/OE Director of Quality and Operations Cryologics, Inc. March 7, 2017 1 About the Presenter Bob Westney, M.S. QA/RA, RAC, CMQ/OE 30 years of industry experience QC Microbiology,
More informationWhy Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services
Why Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services Disclosures I, Ross Caputo, declare no conflicts of interest, real or apparent, and
More informationWorking document QAS/ June 2011 RESTRICTED DRAFT FOR COMMENT
June 2011 RESTRICTED DRAFT PROPOSAL FOR Revision of General method in the 4th Edition of The International Pharmacopoeia 3.3 MICROBIAL PURITY OF PHARMACEUTICAL PREPARATIONS (June 2011) DRAFT FOR COMMENT
More informationGMP Requirements. Gabriel Kaddu, Senior GMP Specialist Promoting the Quality of Medicines Program (PQM) U.S. Pharmacopeial Convention (USP)
GMP Requirements Gabriel Kaddu, Senior GMP Specialist Promoting the Quality of Medicines Program (PQM) U.S. Pharmacopeial Convention (USP) 2016. ALL RIGHTS RESERVED. Outline GMP Procedures and standards
More informationGMP Inspection Process. Types of GMP Inspection. Module 18 Slide 1 of 14 WHO - EDM
GMP Inspection Process Types of GMP Inspection Module 18 Slide 1 of 14 WHO - EDM Objectives 1. To review the different types of inspection 2. To examine when each is appropriate 3. To discuss inspections
More informationMicrobiology for Oral and Topical Products - The basics Scott Colbourne Business Manager NSW ALS Food & Pharmaceutical
Microbiology for Oral and Topical Products - The basics Scott Colbourne Business Manager NSW ALS Food & Pharmaceutical RIGHT S O L U T I O N S RIGHT PARTNER Contents TGO 77 - Introduction Tests Performed
More informationSpecifications. February 19, 2015, TOKYO, JAPAN. Takao Hayakawa, Ph.D. Director, Pharmaceutical Research and Technology Institute, Kindai University
Specifications February 19, 2015, TOKYO, JAPAN Takao Hayakawa, Ph.D. Director, Pharmaceutical Research and Technology Institute, Kindai University Norihisa Sakamoto, M.D., Ph.D. Deputy Review Director
More informationHow to Handle Excursions in Environmental Monitoring (EM) and Personnel Monitoring (PM) in an Aseptic Processing Plant
How to Handle Excursions in Environmental Monitoring (EM) and Personnel Monitoring (PM) in an Aseptic Processing Plant Randy Hutt, Ph.D. Associate Director Sterility Assurance and Microbiology Luitpold
More informationTraining Prospectus Public Course Dates
Training Prospectus 2018 Public Course Dates Honeyman Group Assuring Compliance in Life Science Operating extensively within the global pharmaceutical, biotech, medical device and related healthcare industries,
More informationValidation Needs for Sterilization by Aseptic Filtration
Validation Needs for Sterilization by Aseptic Filtration DCVMN Workshop, Hyderabad, 4-8 April 2016 Ramesh Raju Associate Director - Provantage Validation Services Overview Key Regulatory and Industry guidelines
More informationEU Guidance / Q&A. Greg McGurk, GMP Manager (acting) GMP Conference. 7 February 2017 Dublin
EU Guidance / Q&A Greg McGurk, GMP Manager (acting) GMP Conference 7 February 2017 Dublin TPN Manufacture Q&A TPN Guidance Proposed at IWG that working group be formed to draft guidance Several adverse
More information10/31/2014. Automated and Rapid Microbiological Methods: Selection and Validation. Microbiology: Past. Microbiology: Today
Automated and Rapid Microbiological Methods: Selection and Validation Michael J. Miller, Ph.D. President Microbiology: Past 1683. Anton van Leeuwenhoek observes bacteria 1861. Pasteur disproves spontaneous
More informationMilliflex Rapid Microbiology Detection System
Data Sheet Milliflex Rapid Microbiology Detection System An automated system for rapid, accurate detection of microorganisms The Milliflex Rapid Microbiology Detection System is an automated solution for
More informationProposed Revision of USP General Chapter Radiopharmaceuticals for Positron Emission Tomography Compounding <823>
Proposed Revision of USP General Chapter Radiopharmaceuticals for Positron Emission Tomography Compounding Ravi Ravichandran, Ph.D. Steve Zigler, Ph.D. February 21, 2011 Agenda Rationale for the
More informationTesto Expert Knowledge. The GxP Dictionary 1st edition. Definitions relating to GxP and Quality Assurance
Testo Expert Knowledge The GxP Dictionary 1st edition Definitions relating to GxP and Quality Assurance Note: Some of the information contained in this GxP Dictionary does not apply equally to all countries.
More informationEuropean Pharmacopoeia Reference Standards A Lodi, Head of the Laboratory Department, EDQM, Council of Europe
European Pharmacopoeia Reference Standards A Lodi, Head of the Laboratory Department, EDQM, Council of Europe Content Ph. Eur. Reference Standards General notices, terms and definitions Key attributes
More informationProtocol Reference: Verification Protocol
Protocol Reference: Verification Protocol Contents 1. About BioBall Multishot 550 3 2. About This Protocol 4 3. Safety Precautions 4 4. Protocol Pre-approval 4 5. Protocol Scope 5 5.1. Intended Location
More informationCOMMON DEFICIENCIES IN FINISHED PHARMACEUTICAL PRODUCT (FPP) DOSSIERS
COMMON DEFICIENCIES IN FINISHED PHARMACEUTICAL PRODUCT (FPP) DOSSIERS Additional guidance for manufacturers This note identifies the most common quality related deficiencies in recently assessed dossiers
More information3. Equipment Cleaning Validation for Active Pharmaceutical Ingredients (APIs) 8. Process Validation for Active Pharmaceutical Ingredients (API)
Title: Good Working Practice Validation Requirements Practice Number: 06 Prepared by: Date: Supersedes: Checked by: Date: Date Issued: Approved by: Date: Review Date: Topics: 1. Biological Test Methods
More informationTechnical Whitepaper. Introduction. Comparing 2 nd Generation ATP to Culture-Based Test Methods
Technical Whitepaper Comparing 2 nd Generation ATP to Culture-Based Test Methods Introduction Water is a vital resource for our planet as it is a requirement for all life forms, big and small, including
More informationMicrobial Contamination Testing and Validation Challenges Non-Sterile Products and Raw Materials
Microrite, Inc. brings you this unique learning experience in Microbial Contamination Testing and Validation ; Part of Microrite s step-by-step webinar series. Microbial Contamination Testing and Validation
More informationThe Parenteral Drug Association
C O N F E R E N C E R E P O R T Equipment Cleaning Microbial Control Issues By Destin A. LeBlanc, M.A. Cleaning Validation Technologies Validation: The Parenteral Drug Association (PDA) spring conference
More informationComputerised Systems. Inspection Expectations. Paul Moody, Inspector. 18/10/2013 Slide 1. ISPE GAMP COP Ireland Meeting, Dublin, 17 th October 2013
Computerised Systems Inspection Expectations ISPE GAMP COP Ireland Meeting, Dublin, 17 th October 2013 Paul Moody, Inspector Slide 1 Presentation Contents Brief Introduction to the IMB Regulatory References
More informationNewsletter. News from BSL BIOSERVICE. No. 2 - July 2014
Newsletter No. 2 - July 2014 News from BSL BIOSERVICE we are pleased to announce our next newsletter in a new dress. Our ambition is presenting our future news in a more friendly manner. Many things have
More informationPROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT
August 2010 RESTRICTED PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT Please address any comments on this draft guideline
More informationEU and FDA GMP Regulations: Overview and Comparison
THE QUALITY ASSURANCE JOURNAL, VOL. 2, 55 60 (1997) EU and FDA GMP Regulations: Overview and Comparison The increasing emphasis on global supply of drug products, as well as starting materials and investigational
More informationOverview of a sterility assurance program for PET drugs
Coalition for PET Drug Approval Radiopharmaceutical Sciences Council Overview of a sterility assurance program for PET drugs Eric Webster, PETNET Solutions Disclosures Employee of PETNET Solutions, a Siemens
More informationGetting it Right Microbial Quality Risk Management
Programme Linda Musker Quality Control North West Mark Oldcorne All Wales Pharmaceutical Quality Assurance Getting it Right Microbial Quality Risk Management Strategic Background (MAO) The Problem (LM)
More informationAnnex Draft Annex
Anmerkung 1: Dieses Vergleichsdokument wurde nach bestem Wissen und Gewissen erstellt und ist rechtlich nicht bindend. Es gelten die von der EMA veröffentlichten Dokumente in der jeweiligen Form. Anmerkung
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union
Ref. Ares(2014)968036-28/03/2014 EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products quality, safety and efficacy Brussels, 28 March 2014 EudraLex
More informationValidation Study of Rapid Assays of Bioburden, Endotoxins and Other Contamination
Biocontrol Science, 2016, Vol. 21, No.2, 63 72 Review Validation Study of Rapid Assays of Bioburden, Endotoxins and Other Contamination HIDEHARU SHINTANI Chuo University, Department of Science and Engineering,
More informationSubpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit.
FDA inspections continue to focus on CGMP violations related to basic GMP controls. A survey of Warning Letters issued in 2013 on CMC (Chemistry / Manufacturing / Controls) violations reveals an emphasis
More informationMODULE 2D ENVIRONMENTAL MICROBIOLOGICAL LABORATORY ACCREDITATION PROGRAM (EMLAP) ADDITIONAL REQUIREMENTS
MODULE 2D ENVIRONMENTAL MICROBIOLOGICAL LABORATORY ACCREDITATION PROGRAM (EMLAP) ADDITIONAL REQUIREMENTS 2D.1 SCOPE The AIHA- Laboratory Accreditation Programs (AIHA-LAP), LLC s Environmental Microbiological
More informationCulture Vs. qpcr. Daniel Grandio Gonzalez
Culture Vs. qpcr Daniel Grandio Gonzalez Introduction Legionelosis, Pontiac Fever, Mycobacteriosis Legionella: Hot water tanks, showers, cooling towers, swimming pools Environmental Mycobacteria: Purified
More informationMicrobiological Consideration for Non-Sterile Pharmaceutical
May 1-3, 2012 Javits Center New York, NY Microbiological Consideration for Non-Sterile Pharmaceutical Dr. Leonard W. Mestrandrea Principal Consultant MESTRANDREA CONSULTING LLC Title Date Microbial Control
More informationContents. Contents (13) 1 Production (23)
1 Production (23) 1.A Sanitation (27) 1.A.1 Organisational prerequisites (27) 1.A.2 Sources of contamination (28) 1.A.3 Responsibilities and implementation (29) 1.B Personnel hygiene (31) 1.B.1 Clothing
More informationPharmaceutical Manufacturing Technology Centre
Pharmaceutical Manufacturing Technology Centre Research themes for Initial Research Programme Call for Proposals The Centre will focus on advanced pharmaceutical manufacturing technologies with an initial
More informationMODULE 2D ENVIRONMENTAL MICROBIOLOGICAL LABORATORY ACCREDITATION PROGRAM (EMLAP) ADDITIONAL REQUIREMENTS
MODULE 2D ENVIRONMENTAL MICROBIOLOGICAL LABORATORY ACCREDITATION PROGRAM (EMLAP) ADDITIONAL REQUIREMENTS 2D.1 SCOPE The AIHA- Laboratory Accreditation Programs (AIHA-LAP), LLC s Environmental Microbiological
More informationGeneral European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT
General European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT PA/PH/OMCL (16) 86 R2 MANAGEMENT OF ENVIRONMENTAL CONDITIONS Full document title and reference Document type Management of Environmental
More informationEZ-Fluo System. For rapid detection of spoilage organisms in wine
Application Note EZ-Fluo System For rapid detection of spoilage organisms in wine Many beverage manufacturing processes are susceptible to spoilage organisms like yeast or bacteria contamination. Contamination
More informationOverview of Regulatory Requirements for API and Formulations
Overview of Regulatory Requirements for API and Formulations Sangeeta Sardesai 4-Dec-2010 Definition - Regulatory Requirement The restrictions, licenses, and laws applicable to a product or business, imposed
More informationPresentation Scope. Rapid Microbiological Methods (RMM) Regulatory Acceptance: Policies and Expectations. Rapid microbiological methods:
Rapid Microbiological Methods (RMM) Regulatory Acceptance: Policies and Expectations Karen Longstaff Director, Microbiology Section Laboratories Branch Medical Devices and Product Quality Division, TGA
More informationSwab and Samplers Test Kits Quality control as easy as 1, 2, 3
Swab and Samplers Test Kits Quality control as easy as 1, 2, 3 Merck Millipore is a division of Environmental monitoring Sample, incubate, count Merck Millipore s Samplers and Swab Test Kits simplify routine
More informationTechnological advances in the detection of surface contamination
Technological advances in the detection of surface contamination (Are surfaces more contaminated than we think?) Dr Andrew Kemp PhD Principle Scientific Officer Q Biotechnologies Scientific advances are
More informationSESSION 14. Documentation Requirements and Management for Validation. 30 March Frits Vogt
Validation Services SESSION 14 Documentation Requirements and Management for Validation 30 March 2017 Frits Vogt fritsvogt@valserv.nl Content Documentation Requirements and Management for Validation I.
More informationGrowth Promotion Test Guide for Media Used in Sterility Tests
Growth Promotion Test Guide for Media Used in Sterility Tests The Sterility Test The purpose of the Sterility Test is to determine if a sample of a pharmaceutical product or component is sterile. A satisfactory
More informationIntroduction. Michael J. Miller, Ph.D. RMM»
RMM» Case Study of a New Growth-based Rapid Microbiological Method (RMM) that Detects the Presence of Specific Organisms and Provides an Estimation of Viable Cell Count Michael J. Miller, Ph.D. President
More informationIN THIS SECTION MICROBIOLOGY TESTING EXPERT SOLUTIONS FOR PRODUCT DEVELOPMENT. Bacterial Endotoxin (LAL) Testing
EXPERT SOLUTIONS FOR PRODUCT DEVELOPMENT IN THIS SECTION MICROBIOLOGY TESTING Microbial assays involve a variety of tests, from the determination of the numbers and types of organisms naturally present
More informationNHS QA Symposium, September 2013
1 www.pmtgb.com Germany - Benelux T o g e t h e r W e c r e a t e S o l u t i o n s France - Great Britain NHS QA Symposium, September 2013 John Cobb Microbiology Support Manager 2 www.pmtgb.com Germany
More informationQuality Implementation Working Group on Q8, Q9 and Q10 Questions & Answers
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE Quality Implementation Working Group on Q8, Q9 and Q10 & Current version dated June
More informationUSP Chapter 823 USP 32 (old) vs. USP 35 (new)
USP Chapter 823 USP 32 (old) vs. USP 35 (new) Sally W. Schwarz, MS, BCNP Research Associate Professor of Radiology Washington University School of Medicine St. Louis, MO Why USP Chapter ? FDA has
More informationCompounding Pharmacies and the Contract Testing Lab
Compounding Pharmacies and the Contract Testing Lab Scott Sutton, Ph.D. scott.sutton@microbiol.org 1 Disclaimer I am making this presentation as an independent agent I am not making this presentation as
More information